Apo-Olmesartan/Hctz 12.5 mg

APO-OLMESARTAN/HCTZ 12.5 MG tablets combine olmesartan and hydrochlorothiazide for blood pressure management. This medication is used to treat hypertension, helping to lower blood pressure effectively.

APO-OLMESARTAN/HCTZ 12.5 MG tablets are primarily used for the treatment of high blood pressure, also known as hypertension. This combination medication works by relaxing blood vessels and reducing fluid retention, which helps to lower blood pressure. It is often prescribed when a single medication is not effective enough. The hydrochlorothiazide component is a diuretic that helps the kidneys remove excess salt and water from the body, while olmesartan is an angiotensin II receptor blocker that helps to widen blood vessels.

Common effects of APO-OLMESARTAN/HCTZ 12.5 MG tablets may include dizziness, headache, and fatigue. Some users might experience dehydration or electrolyte imbalances due to the diuretic effect. It is important to stay hydrated and monitor for signs of dizziness or lightheadedness, especially when starting the medication or adjusting the dose.

APO-OLMESARTAN/HCTZ 12.5 MG tablets should be used with caution in individuals with kidney or liver problems. It is important to follow the prescribed dosage and not to stop taking the medication without consulting a healthcare provider. Regular monitoring of blood pressure and kidney function may be necessary. Pregnant women should avoid this medication unless specifically advised by a healthcare professional.

APO-OLMESARTAN/HCTZ 12.5 MG tablets may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), lithium, and certain diabetes medications. Alcohol can enhance the blood pressure-lowering effects and increase the risk of dizziness. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.